“SARS-CoV-2 recombinant proteins stimulate distinct cellular and humoral immune response profiles in samples from COVID-19 convalescent patients”, Clinics, vol. 76, p. e3548, Jun. 2023, doi: 10.6061/clinics/2021/e3548.